Logo image
Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency
Journal article   Open access   Peer reviewed

Neurosarcoidosis-associated central diabetes insipidus masked by adrenal insufficiency

Lemuel Non, Daniel Brito and Catherine Anastasopoulou
BMJ case reports, Vol.2015(jan22 1), pp.bcr2014206390-bcr2014206390
2015
DOI: 10.1136/bcr-2014-206390
PMCID: PMC4307084
PMID: 25612752
url
https://europepmc.org/articles/pmc4307084View
Published (Version of record) Open Access

Abstract

Central diabetes insipidus (CDI) is an infrequent complication of neurosarcoidosis (NS). Its presentation may be masked by adrenal insufficiency (AI) and uncovered by subsequent steroid replacement. A 45-year-old woman with a history of NS presented 2 weeks after abrupt cessation of prednisone with nausea, vomiting, decreased oral intake and confusion. She was diagnosed with secondary AI and intravenous hydrocortisone was promptly begun. Over the next few days, however, the patient developed severe thirst and polyuria exceeding 6 L of urine per day, accompanied by hypernatraemia and hypo-osmolar urine. She was presumed to have CDI due to NS, and intranasal desmopressin was administered. This eventually normalised her urine output and serum sodium. The patient was discharged improved on intranasal desmopressin and oral prednisone. AI may mask the manifestation of CDI because low serum cortisol impairs renal-free water clearance. Steroid replacement reverses this process and unmasks an underlying CDI.

Details

Metrics

10 Record Views
Logo image